Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Elsinga

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Neuroimage|June 7, 2017
Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesiaX Zhou, J Doorduin, P H Elsinga, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
A feasibility study on L-[1-carbon-11]tyrosine and L-[methyl-carbon-11]methionine to assess liver protein synthesis by PETK Ishiwata, K Enomoto, T Sasaki, et al.
Cancer Research|April 1, 1991
A fluorine-18 labeled progestin as an imaging agent for progestin receptor positive tumors with positron emission tomographyA Verhagen, P H Elsinga, T J de Groot, et al.
Current Pharmaceutical Design|November 11, 2008
Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticalsH J K Ananias, I J de Jong, R A Dierckx, et al.
Nuclear Medicine and Biology|August 30, 2000
Quantitative imaging of 5-HT(1A) receptor binding in healthy volunteers with [(18)f]p-MPPFJ Passchier, A van Waarde, R M Pieterman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 18, 2000
In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPFJ Passchier, A van Waarde, R M Pieterman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 15, 2002
New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanomaD C P Cobben, S Koopal, A T M G Tiebosch, et al.
European Journal of Pharmacology|December 16, 1998
Characterisation of beta2-adrenoceptors, using the agonist [11C]formoterol and positron emission tomographyT J Visser, A van Waarde, P Doze, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 5, 2005
Positron emission tomography in patients with breast cancer using (18)F-3'-deoxy-3'-fluoro-l-thymidine ((18)F-FLT)-a pilot studyL B Been, P H Elsinga, J de Vries, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 1999
Detection of muscarinic receptors in the human lung using PETT J Visser, A van Waarde, T W van der Mark, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Neuroimage|June 7, 2017
Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesiaX Zhou, J Doorduin, P H Elsinga, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
A feasibility study on L-[1-carbon-11]tyrosine and L-[methyl-carbon-11]methionine to assess liver protein synthesis by PETK Ishiwata, K Enomoto, T Sasaki, et al.
Cancer Research|April 1, 1991
A fluorine-18 labeled progestin as an imaging agent for progestin receptor positive tumors with positron emission tomographyA Verhagen, P H Elsinga, T J de Groot, et al.
Current Pharmaceutical Design|November 11, 2008
Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticalsH J K Ananias, I J de Jong, R A Dierckx, et al.
Nuclear Medicine and Biology|August 30, 2000
Quantitative imaging of 5-HT(1A) receptor binding in healthy volunteers with [(18)f]p-MPPFJ Passchier, A van Waarde, R M Pieterman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 18, 2000
In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPFJ Passchier, A van Waarde, R M Pieterman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 15, 2002
New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanomaD C P Cobben, S Koopal, A T M G Tiebosch, et al.
European Journal of Pharmacology|December 16, 1998
Characterisation of beta2-adrenoceptors, using the agonist [11C]formoterol and positron emission tomographyT J Visser, A van Waarde, P Doze, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 5, 2005
Positron emission tomography in patients with breast cancer using (18)F-3'-deoxy-3'-fluoro-l-thymidine ((18)F-FLT)-a pilot studyL B Been, P H Elsinga, J de Vries, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 1999
Detection of muscarinic receptors in the human lung using PETT J Visser, A van Waarde, T W van der Mark, et al.
Pageof 7